167 related articles for article (PubMed ID: 38391311)
41. A Potential Radiomics-Clinical Model for Predicting Failure of Lymph Node Control after Definite Radiotherapy in Locally Advanced Head and Neck Cancer.
Lee S; Park S; Rim CH; Lee YH; Kwon SY; Oh KH; Yoon WS
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256353
[No Abstract] [Full Text] [Related]
42. Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.
Zhou S; Rulach R; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Lau YC; Paterson C
Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):665-673. PubMed ID: 32561027
[TBL] [Abstract][Full Text] [Related]
43. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy.
Lee TF; Fang FM
Radiother Oncol; 2013 Mar; 106(3):352-8. PubMed ID: 23333019
[TBL] [Abstract][Full Text] [Related]
44. Role of primary tumor volume and metastatic lymph node volume in response to curative effect of definitive radiotherapy for locally advanced head and neck cancer.
Mao W; Zhang T; Li L; Peng S; Gong H; Li M
Eur J Med Res; 2024 Feb; 29(1):98. PubMed ID: 38311769
[TBL] [Abstract][Full Text] [Related]
45. "Christie Regimen" palliative radiotherapy in advanced head-and-neck cancer: A single-center experience.
Srivastava A; Adhikari N; Sonkar DR; Singh K; Rathi AK
J Cancer Res Ther; 2021; 17(1):88-93. PubMed ID: 33723137
[TBL] [Abstract][Full Text] [Related]
46. Prediction of extranodal extension in head and neck squamous cell carcinoma by CT images using an evolutionary learning model.
Huang TT; Lin YC; Yen CH; Lan J; Yu CC; Lin WC; Chen YS; Wang CK; Huang EY; Ho SY
Cancer Imaging; 2023 Sep; 23(1):84. PubMed ID: 37700385
[TBL] [Abstract][Full Text] [Related]
47. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
48. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
[TBL] [Abstract][Full Text] [Related]
49. Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma.
Wang F; Zhang W; Chai Y; Wang H; Liu Z; He Y
Front Immunol; 2022; 13():1015436. PubMed ID: 36458007
[TBL] [Abstract][Full Text] [Related]
50. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
51. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
[TBL] [Abstract][Full Text] [Related]
52. Predictive quantitative ultrasound radiomic markers associated with treatment response in head and neck cancer.
Tran WT; Suraweera H; Quaioit K; Cardenas D; Leong KX; Karam I; Poon I; Jang D; Sannachi L; Gangeh M; Tabbarah S; Lagree A; Sadeghi-Naini A; Czarnota GJ
Future Sci OA; 2019 Nov; 6(1):FSO433. PubMed ID: 31915534
[TBL] [Abstract][Full Text] [Related]
53. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
54. Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.
Huang J; Chunta JL; Amin M; Lee DY; Grills IS; Wong CY; Yan D; Marples B; Martinez AA; Wilson GD
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):485-91. PubMed ID: 22331000
[TBL] [Abstract][Full Text] [Related]
55. Machine learning-based MRI radiomics for assessing the level of tumor infiltrating lymphocytes in oral tongue squamous cell carcinoma: a pilot study.
Ren J; Yang G; Song Y; Zhang C; Yuan Y
BMC Med Imaging; 2024 Feb; 24(1):33. PubMed ID: 38317076
[TBL] [Abstract][Full Text] [Related]
56. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.
Kaae JK; Johnsen L; Hansen CR; Kristensen MH; Brink C; Eriksen JG
Acta Oncol; 2019 Oct; 58(10):1366-1372. PubMed ID: 31241381
[No Abstract] [Full Text] [Related]
57. Utility of diffusion MRI characteristics of cervical lymph nodes as disease classifier between patients with head and neck squamous cell carcinoma and healthy volunteers.
Papoutsaki MV; Sidhu HS; Dikaios N; Singh S; Atkinson D; Kanber B; Beale T; Morley S; Forster M; Carnell D; Mendes R; Punwani S
NMR Biomed; 2021 Nov; 34(11):e4587. PubMed ID: 34240782
[TBL] [Abstract][Full Text] [Related]
58. Dosimetric parameters predictive of nasolacrimal duct obstruction after carbon-ion radiotherapy for head and neck carcinoma.
Kubo N; Kubota Y; Kawamura H; Oike T; Sakai M; Kumazawa T; Miyasaka Y; Okazaki S; Kobayashi D; Sato H; Mizukami T; Musha A; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T; Nakano T
Radiother Oncol; 2019 Dec; 141():72-77. PubMed ID: 31439449
[TBL] [Abstract][Full Text] [Related]
59. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
60. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
PLoS One; 2018; 13(7):e0200137. PubMed ID: 29979726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
